| Primary |
| Hypertension |
47.2% |
| Product Used For Unknown Indication |
13.9% |
| Diffuse Large B-cell Lymphoma |
4.6% |
| Cardiac Failure |
3.7% |
| Asthma |
2.8% |
| Coronary Artery Disease |
2.8% |
| Prophylaxis |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Arteriosclerosis |
1.9% |
| Arthralgia |
1.9% |
| Atrial Fibrillation |
1.9% |
| Cardiac Failure Chronic |
1.9% |
| Depression |
1.9% |
| Diabetes Mellitus Non-insulin-dependent |
1.9% |
| Dyspnoea |
1.9% |
| Oedema |
1.9% |
| Pain |
1.9% |
| Analgesic Therapy |
0.9% |
| Angina Pectoris |
0.9% |
| Antiviral Prophylaxis |
0.9% |
|
| Oligohydramnios |
19.4% |
| Renal Failure Acute |
11.1% |
| Hypersensitivity |
8.3% |
| Syncope |
8.3% |
| Nervousness |
5.6% |
| Renal Impairment |
5.6% |
| Urinary Tract Infection |
5.6% |
| Atrial Septal Defect |
2.8% |
| Dysgeusia |
2.8% |
| Extremity Contracture |
2.8% |
| Feeling Abnormal |
2.8% |
| Flatulence |
2.8% |
| Glycosylated Haemoglobin Increased |
2.8% |
| Haemorrhage |
2.8% |
| Hepatic Failure |
2.8% |
| Microcephaly |
2.8% |
| Off Label Use |
2.8% |
| Pain In Extremity |
2.8% |
| Paraesthesia |
2.8% |
| Patent Ductus Arteriosus |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
40.6% |
| Hypertension |
21.8% |
| Drug Use For Unknown Indication |
11.4% |
| Asthma |
2.9% |
| Diabetes Mellitus |
2.4% |
| Atrial Fibrillation |
2.2% |
| Cardiac Failure |
2.2% |
| Migraine Prophylaxis |
1.8% |
| Drug Exposure During Pregnancy |
1.6% |
| Renal Cell Carcinoma |
1.6% |
| Non-hodgkin's Lymphoma |
1.4% |
| Prophylaxis |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Migraine |
1.2% |
| Schizophrenia |
1.2% |
| Arthralgia |
1.0% |
| Bipolar I Disorder |
1.0% |
| Depression |
0.8% |
| Epilepsy |
0.8% |
| Gastric Cancer |
0.8% |
|
| Renal Failure Acute |
10.7% |
| Abnormal Dreams |
9.3% |
| Vomiting |
9.3% |
| Nervousness |
6.7% |
| Syncope |
6.7% |
| Feeling Abnormal |
5.3% |
| Liver Disorder |
5.3% |
| Loss Of Consciousness |
5.3% |
| Testicular Swelling |
5.3% |
| Diabetes Mellitus Inadequate Control |
4.0% |
| Hypotension |
4.0% |
| Pneumonia |
4.0% |
| Skull Malformation |
4.0% |
| Swollen Tongue |
4.0% |
| Hallucination |
2.7% |
| Jaundice |
2.7% |
| Presyncope |
2.7% |
| Renal Impairment |
2.7% |
| Respiratory Failure |
2.7% |
| Retinopathy Of Prematurity |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.8% |
| Hypertension |
19.0% |
| Drug Use For Unknown Indication |
16.4% |
| Atrial Fibrillation |
3.4% |
| Rheumatoid Arthritis |
3.3% |
| Pain |
3.0% |
| Diabetes Mellitus |
2.6% |
| Type 2 Diabetes Mellitus |
2.3% |
| Prophylaxis |
2.2% |
| Depression |
2.1% |
| Cardiac Failure |
2.1% |
| Osteoporosis |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Hyperlipidaemia |
1.0% |
| Myocardial Ischaemia |
1.0% |
| Angina Pectoris |
0.9% |
| Myocardial Infarction |
0.9% |
| Breast Cancer |
0.9% |
| Asthma |
0.8% |
| Multiple Myeloma |
0.8% |
|
| Renal Failure Acute |
10.5% |
| Vomiting |
8.6% |
| Wheezing |
6.7% |
| Weight Decreased |
6.4% |
| Pyrexia |
6.2% |
| Myalgia |
6.0% |
| Tremor |
5.7% |
| Rhabdomyolysis |
5.5% |
| Weight Increased |
5.0% |
| International Normalised Ratio Increased |
4.5% |
| Thrombocytopenia |
4.5% |
| Malaise |
4.0% |
| Renal Failure |
4.0% |
| Nausea |
3.6% |
| Sepsis |
3.3% |
| Urinary Tract Infection |
3.3% |
| Dyspnoea |
3.1% |
| Hypotension |
3.1% |
| Pneumonia |
3.1% |
| Hypomagnesaemia |
2.9% |
|
| Interacting |
| Hypertension |
26.1% |
| Blood Pressure Increased |
21.7% |
| Blood Pressure Abnormal |
17.4% |
| Pulmonary Hypertension |
8.7% |
| Arteriosclerosis Coronary Artery |
4.3% |
| Atrial Fibrillation |
4.3% |
| Muscle Spasms |
4.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.3% |
| Tachyarrhythmia |
4.3% |
| Tuberculosis |
4.3% |
|
| Drug Interaction |
25.0% |
| Vestibular Disorder |
25.0% |
| Vomiting |
25.0% |
| Weight Decreased |
25.0% |
|
